MOLECULAR CHARACTERIZATION OF MUTANT TP53 ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME. Grob T, Al Hinai AS, Sanders MA, Kavelaars F, et al. Blood 2022 Feb 2. pii: 483799. doi: 10.1182/blood.2021014472.

Read + Share

Amedeo Smart

Independent Medical Education

Grob T, Al Hinai AS, Sanders MA, Kavelaars F, et al. MOLECULAR CHARACTERIZATION OF MUTANT TP53 ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME. Blood 2022 Feb 2. pii: 483799. doi: 10.1182/blood.2021014472.
PMID: 35108372